Skip to main content

Anti-phospho-Ubiquitin (Ser65) (C15-1317-722)

Catalog No.
C15-1317-722
Manufacturer No.
ABS1513-I
Manufacturer Name
Sigma-Aldrich
Quantity
100
Unit of Measure
UL
Price: $798.86
List Price: $887.62

Ubiqutin (Ub) is initially produced as a 229-a.a.

Enjoy exclusive benefits including discounted pricing on orders by contacting our Sales Executives to open an account.

Adding to cart… The item has been added

General description

Ubiqutin (Ub) is initially produced as a 229-a.a. Polyubiquitin-B (UniProt P0CG47) precursor protein encoded by the UBB gene (Gene ID 7314) or a 685-a.a. Polyubiquitin-C precursor protein (UniProt P0CG48) encoded by the UBC gene (Gene ID 7316) in human. The C-termini of Polyubiquitin-B (Cys229) and Polyubiquitin-C (Val685) are post-translationally removed, followed by additional posttranslational cleavages to yield multiple copies of idential 76-amino acid ubiquitin (also known as high mobility group nonhistone protein HMG-20) molecules (three copies per Polyubiquitin-B and nine copies per Polyubiquitin-C). Covalent modifications of target proteins via different Ub Lys residues are well documented events during cellular DNA repair, ER-associated degradation (ERAD), transcription activation, lysosomal and proteasomal degradation. PINK1 (PTEN induced putative kinase 1) is a Ser/Thr kinase that specifically accumulates in depolarized mitochondria, where it acts as a positive regulator of parkin (Park2) E3 ubiquitin (Ub) ligase activity by phosphorylating Ub at Ser65 as well as the corresponding Ser residue in parkin N-terminal Ub-like (UBL) domain. Phosphorylated Ub interacts with phosphorylated parkin at its GINGO0 domain in an allosteric manner, inducing a conformation change and exposing parkin RING2 domain catalytic cysteine for full ligase activity. NMR based conformation study reveals that Ser65-phosphorylated Ub exists in two conformations in solution. The major conformation displays altered surface properties, while the second phosphoUb conformation exhibits a retracted C-terminal tail by two residues into the Ub core. Ub Ser65 phosphorylation has little effect toward E1-mediated E2 charging and mainly affects the discharging of E2 enzymes to form polyUb chains. In addition, the majority of deubiquitinases (DUBs), including USP8, USP15 and USP30, are shown to exhibit impaired activity against Lys63-linked poly-phosphoUb.

Specificity

Expected to react with a broad-range of species based on 100% sequence homology.

This polyclonal antibody detects only Ser65-phosphorylated ubiquitin (Ub) and ubiquitinated proteins (including oligoUb and polyUb) containing Ser65-phosphorylated ubiquitin. No reactivity toward Ub or ubiquitinated proteins in the absence of Ub Ser65 phosphorylation.

Immunogen

KLH-conjugated linear peptide corresponding to the ubiquitin target region sequence containing phosphorylated Ser65.

Application

Detect ubiquitin Ser65 phosphorylation using this rabbit polyclonal Anti-phospho-Ubiquitin (Ser65), Cat. No. ABS1513-I, validated for use in Immunocytochemistry and Western Blotting.

Immunocytochemistry Analysis: A 1:500 dilution from a representative lot detected CCCP (Cat. No. 215911) treatment-induced ubiquitin Ser65 phosphorylation in PINK1-expressing HeLa cells.

Western Blotting Analysis: A 1:5,000 dilution from a representative lot detected GST-PINK1-catalyzed Ser65 phosphorylation of recombinant Ubiquitin.

Immunocytochemistry Analysis: A 1:200 dilution from a representative lot detected phospho-Ubiquitin (Ser65) in PINK1 expressing HeLa cells without and with CCCP treatment. (Courtesy of Dr. Noriyuki Matsuda).

Quality

Evaluated by Western Blotting in PINK1-expressing HeLa cells.

Western Blotting Analysis: A 1:1,000 dilution of this antibody detected cellular ubiquitin Ser65 phosphorylation induction in 10 µg of lysate from PINK1-expressing HeLa cells upon CCCP (Cat. No. 215911) treatment.

Target description

~17/8 and ~45-250 kDa observed. 8.565/17.112/25.66/34.21 kDa (mono-/di/tri-/tetra-ubiquitin) calculated. Bands ~45-250 kDa represent ubiquitinated proteins containing ser65-phosphorylated Ub. Uncharacterized bands may be observed in some lysate(s).

Linkage

Replaces: ABS1513

Other Notes

Concentration: Please refer to lot specific datasheet.

biological source: rabbit. Quality Level: 100. antibody form: affinity isolated antibody. antibody product type: primary antibodies. clone: polyclonal. purified by: affinity chromatography. species reactivity: human. species reactivity (predicted by homology): mouse (based on 100% sequence homology), guinea pig (based on 100% sequence homology), rat (based on 100% sequence homology), horse (based on 100% sequence homology), sheep (based on 100% sequence homology), bovine (based on 100% sequence homology), hamster (based on 100% sequence homology), nonhuman primates (based on 100% sequence homology). technique(s): immunocytochemistry: suitable, western blot: suitable. NCBI accession no.: NP_061828, NP_066289. UniProt accession no.: P0CG47. shipped in: ambient. target post-translational modification: phosphorylation (pSer65). Gene Information: human ... UBB(7314). Storage Class Code: 12 - Non Combustible Liquids. WGK: WGK 1. Flash Point(F): Not applicable. Flash Point(C): Not applicable.
UPC:
51282131
Condition:
New
Weight:
1.00 Ounces
HazmatClass:
No
WeightUOM:
LB
MPN:
ABS1513-I


Cenmed Satisfaction Guarantee

At Cenmed, your confidence and satisfaction are paramount. We guarantee the quality and reliability of our extensive range of clinical and laboratory supplies. If you're not completely satisfied with your purchase, we offer a straightforward return process and dedicated support to resolve your concerns promptly. Our commitment ensures that you can order with confidence, knowing that Cenmed is dedicated to superior service and customer satisfaction. Trust us to meet your needs with every order, backed by our promise of excellence. Learn more in Help & FAQs.


"Cenmed provides me access to the same products/services normally reserved for much larger labs than mine. I was presently surprised by their product offering."

LAB DIRECTOR


"We utilized Cenmed's capabilities for a variety of projects around the world. They are a valued partner and supplier."

PHARMACEUTICAL SUPPLY CHAIN LEADER


"The reps are very good at finding products for customers in this period of supply chain issues."

SCOTT BEHMAN


"Your customer service has been excellent and makes me excited about purchasing with Cenmed in the future!!"

PROCUREMENT + BILLING COORDINATOR AT PHARMA.